Merck & Co Inc
NYSE:MRK

Watchlist Manager
Merck & Co Inc Logo
Merck & Co Inc
NYSE:MRK
Watchlist
Price: 98.98 USD 0.95%
Market Cap: 250.4B USD
Have any thoughts about
Merck & Co Inc?
Write Note

Intrinsic Value

The intrinsic value of one MRK stock under the Base Case scenario is 137.21 USD. Compared to the current market price of 98.98 USD, Merck & Co Inc is Undervalued by 28%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MRK Intrinsic Value
137.21 USD
Undervaluation 28%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Merck & Co Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
MRK
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MRK cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about MRK?
Bearish
Neutral
Bullish

Fundamental Analysis

98.98 USD
+0.95%
+0.95%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Merck & Co Inc
US
Pharmaceuticals
Market Cap
250.6B USD
IPO
Jan 1, 1941
Employees
68 000
United States of America
Market Cap
250.6B USD
Industry
Pharmaceuticals
IPO
Jan 1, 1941
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Merck & Co Inc

Provide an overview of the primary business activities
of Merck & Co Inc.

What unique competitive advantages
does Merck & Co Inc hold over its rivals?

What risks and challenges
does Merck & Co Inc face in the near future?

Has there been any significant insider trading activity
in Merck & Co Inc recently?

Summarize the latest earnings call
of Merck & Co Inc.

What significant events have occurred
in Merck & Co Inc over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Merck & Co Inc.

Provide P/S
for Merck & Co Inc.

Provide P/E
for Merck & Co Inc.

Provide P/OCF
for Merck & Co Inc.

Provide P/FCFE
for Merck & Co Inc.

Provide P/B
for Merck & Co Inc.

Provide EV/S
for Merck & Co Inc.

Provide EV/GP
for Merck & Co Inc.

Provide EV/EBITDA
for Merck & Co Inc.

Provide EV/EBIT
for Merck & Co Inc.

Provide EV/OCF
for Merck & Co Inc.

Provide EV/FCFF
for Merck & Co Inc.

Provide EV/IC
for Merck & Co Inc.

Show me price targets
for Merck & Co Inc made by professional analysts.

What are the Revenue projections
for Merck & Co Inc?

How accurate were the past Revenue estimates
for Merck & Co Inc?

What are the Net Income projections
for Merck & Co Inc?

How accurate were the past Net Income estimates
for Merck & Co Inc?

What are the EPS projections
for Merck & Co Inc?

How accurate were the past EPS estimates
for Merck & Co Inc?

What are the EBIT projections
for Merck & Co Inc?

How accurate were the past EBIT estimates
for Merck & Co Inc?

Compare the revenue forecasts
for Merck & Co Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Merck & Co Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Merck & Co Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Merck & Co Inc compared to its peers.

Compare the P/E ratios
of Merck & Co Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Merck & Co Inc with its peers.

Analyze the financial leverage
of Merck & Co Inc compared to its main competitors.

Show all profitability ratios
for Merck & Co Inc.

Provide ROE
for Merck & Co Inc.

Provide ROA
for Merck & Co Inc.

Provide ROIC
for Merck & Co Inc.

Provide ROCE
for Merck & Co Inc.

Provide Gross Margin
for Merck & Co Inc.

Provide Operating Margin
for Merck & Co Inc.

Provide Net Margin
for Merck & Co Inc.

Provide FCF Margin
for Merck & Co Inc.

Show all solvency ratios
for Merck & Co Inc.

Provide D/E Ratio
for Merck & Co Inc.

Provide D/A Ratio
for Merck & Co Inc.

Provide Interest Coverage Ratio
for Merck & Co Inc.

Provide Altman Z-Score Ratio
for Merck & Co Inc.

Provide Quick Ratio
for Merck & Co Inc.

Provide Current Ratio
for Merck & Co Inc.

Provide Cash Ratio
for Merck & Co Inc.

What is the historical Revenue growth
over the last 5 years for Merck & Co Inc?

What is the historical Net Income growth
over the last 5 years for Merck & Co Inc?

What is the current Free Cash Flow
of Merck & Co Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Merck & Co Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Merck & Co Inc

Current Assets 40.4B
Cash & Short-Term Investments 14.6B
Receivables 12.2B
Other Current Assets 13.6B
Non-Current Assets 77.2B
Long-Term Investments 1.8B
PP&E 23.4B
Intangibles 38.7B
Other Non-Current Assets 13.3B
Current Liabilities 29.6B
Accounts Payable 3.6B
Accrued Liabilities 15.7B
Other Current Liabilities 10.3B
Non-Current Liabilities 43.4B
Long-Term Debt 35B
Other Non-Current Liabilities 8.5B
Efficiency

Earnings Waterfall
Merck & Co Inc

Revenue
63.2B USD
Cost of Revenue
-14.8B USD
Gross Profit
48.4B USD
Operating Expenses
-26.7B USD
Operating Income
21.7B USD
Other Expenses
-9.5B USD
Net Income
12.1B USD

Free Cash Flow Analysis
Merck & Co Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MRK Profitability Score
Profitability Due Diligence

Merck & Co Inc's profitability score is 69/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Exceptional 3-Year Average ROE
Positive Operating Income
69/100
Profitability
Score

Merck & Co Inc's profitability score is 69/100. The higher the profitability score, the more profitable the company is.

MRK Solvency Score
Solvency Due Diligence

Merck & Co Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
68/100
Solvency
Score

Merck & Co Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MRK Price Targets Summary
Merck & Co Inc

Wall Street analysts forecast MRK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRK is 131.54 USD with a low forecast of 101 USD and a high forecast of 162.75 USD.

Lowest
Price Target
101 USD
2% Upside
Average
Price Target
131.54 USD
33% Upside
Highest
Price Target
162.75 USD
64% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MRK?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MRK is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MRK Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

MRK News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one MRK stock?

The intrinsic value of one MRK stock under the Base Case scenario is 137.21 USD.

Is MRK stock undervalued or overvalued?

Compared to the current market price of 98.98 USD, Merck & Co Inc is Undervalued by 28%.

Back to Top